[Ip-health] PRESS RELEASE - Horizon 2020: We all invest, who gets the return?

david at davidhammerstein.org david at davidhammerstein.org
Wed Nov 30 11:49:53 PST 2011

Horizon 2020: We all invest, who gets the return?
30 November 2011
At the same time as the European Commission presented its Research and Innovation Framework programme – Horizon 2020, Health Action International (HAI) Europe and Trans Atlantic Consumer Dialogue (TACD) organized an expert conference to examine how this proposal will invest 80 billion Euros of taxpayers’ money in economically and socially sustainable innovation models. The present financial crisis calls for bold experimentation with new innovation models that guarantee more openness, easier accessibility and higher result-oriented efficiency.
Mariana Mazzucato, Professor in Economics at the University of Sussex, underlined the role of the State as a catalyst of innovation. She argued that research models should avoid socializing the risks of investment while privatizing the profits of innovation by ensuring the public receives return on its investment.  
Peter Gøtzsche, Director of the The Nordic Cochrane Centre, spoke about the need to strengthen and open up the European Union’s (EU) health research. “Data sharing would lead to tremendous benefits for patients, progress in science, and much more rational use of healthcare resources based on evidence we can trust,” he said.
Glyn Moody, open source technology expert, used the example of the IT sector to underline how open access and citizen based research can indeed be good business both financially and socially.
Katrina Perehudoff, HAI Europe, urged: “The time to act is now and Horizon 2020 offers an excellent opportunity for the EU to explore new models of innovation that ensure EU-funded medical research results in affordable and accessible medicines. This is yet to be achieved in today’s release of the Horizon 2020 proposal.”
David Hammerstein, TACD, explained: “Tax money should be spent in the public interest, not to create intellectual property only for the benefit of private companies. The Horizon 2020 should include socially-fair rules on the management of intellectual property rights, research results and technology transfer to assure affordability, accessibility and transparency.”
The recordings from the conference are available here: http://www.greenmediabox.eu/archive/2011/11/30/horizon2020  
Link to TACD/HAI Europe Executive Summary of EU Policy Opportunities in Biomedical Innovation & the Public Good: http://tacd-ip.org/archives/507
For further information, please contact David Hammerstein of TACD (+32474472763, David.hammerstein at tacd.org) or Katrina Perehudoff of HAI Europe (Katrina at haieurope.org)
Katrina Perehudoff
Health Action International, Europe
Overtoom 60/II
1054 HK Amsterdam
The Netherlands
Tel: +31 20 683 3684
Fax: +31 20 685 5002
Email: katrina at haieurope.org
Please be aware that I do not work on Tuesdays and Fridays.
HAI Europe staff blog about recent developments in medicines policy at: www.haieuropestaffblog.blogspot.com/
Health Action International (HAI) is an independent, global network working to increase access to essential medicines and improve their rational use through research excellence and evidence-based advocacy.
Important Email Information:
The information contained in this email is confidential and may be legally privileged.  It is intended solely for the addressee and is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s), please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. If you are not the intended addressee, please contact the sender and dispose of this e-mail immediately. Any opinions expressed are those of the author, not of HAI.

More information about the Ip-health mailing list